IXICO's digital expertise to be deployed in clinical trial as it lands US$2.7mln contract
The seven-year deal, which starts immediately, builds on a relationship with an existing customer
Company
IXICO PLC
LON:IXI
IXICO is no ordinary Imaging Contract Research Organisation (iCRO). By unlocking valuable insights into drug safety and efficacy, IXICO has built a highly respected global reputation and a 20-year track record as an end-to-end iCRO. IXICO addresses the complex biomarker challenges associated with neurodegenerative conditions, expertly managing and analysing neuroimaging clinical trials in areas such as Alzheimer’s, Parkinson’s, Huntington's and other rare diseases.
263 stories · page 12 of 14
FTSE 100 finishes sharply lower as financial stocks weigh
FTSE 100, which has been hitting record highs over the past weeks, hit a five week low
Archive
Proactive news snapshot: Learning Technologies, Solo Oil, Bushveld Minerals …
A glance at some of the day's highlights from the Proactive Investors newswire
Investments and investor services
Connect plunges as speculators play pass the parcel
A look at some of the day's major movers, such as Indivior, Greatland Gold, Ocado, Connect Group, Quadrise Fuels.
IXICO says the New Year has started well
Chairman Charles Spicer was set to deliver an upbeat statement at Monday's AGM
IXICO reduces losses in year of transition
IXICO's mission is to transform the pursuit of improving brain health through the application of digital technologies
Archive
Proactive news snapshot: Tavistock Investments, European Metals Holdings, KEFI Minerals …
A glance at some of the day's highlights from the Proactive Investors newswire
IXICO defines its growth strategy with continued focus on neurological disorders
"On our path to profitability, we will seek to ensure that IXICO captures its share of the value being created by incredibly exciting and disruptive digital health tools"
Ocado shares stay strong, Physiomics soars, but Torotrak tumbles
Some of the biggest risers and fallers in London on Monday
Investments and investor services
FTSE 100 makes strong gains with Royal Dutch Shell in support
London's FTSE 100 closed the day sharply higher, up over 1% to 7,460
Archive
Proactive news snapshot: Lionsgold, Iofina, IXICO, Ades, Nanobiotix
A look at some of the day's highlights from the Proactive Investors newswire
IXICO wins £750,000 wrist monitor deal
The deal, the second of its kind, is with an unnamed leading biopharmaceutical and is worth £750,000 over two years
Archive
Proactive news snapshot: Symphony Environmental, Plexus Holdings, Landore Resources …
A glance at some of the day's highlights from the Proactive Investors newswire
Order boost means IXICO ends year strongly
Revenues in the year to September will be about 20% higher that a year ago at £3.7mln
IXICO signs new contract, worth US$690,000 for its technology enabled imaging services
The AIM-listed digital technologies company said the contract is for a Phase II clinical trial evaluating the safety and tolerability of a novel treatment for patients with Huntington's disease.
Archive
Proactive news snapshot: Hurricane Energy, Ceres Power, Plexus Holdings …
A glance at some of the day's highlights from the Proactive Investors newswire
MBL Group's top two throw in the towel after hitting snags in the sale process
Former directors are proving to be flies in the ointment at MBL Group and Altona Energy
IXICO to work on Huntington's disease trial for US biopharma
The contract value is £1.2mln over a three year term
FTSE 100 closes lower at 7,301 as pound eases against US dollar
FTSE 100 closed 9.35 lower at 7,301 and the FTSE 250 added over 49 points at 19,566